A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
Clinical trial NCT03073213 · COMPLETED
Trial details
- NCT number
- NCT03073213
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-13
- Primary completion
- 2019-05-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.